Ipamorelin vs. Hexarelin
Head-to-head comparison based on the profiles in the PepCycle library.
| Attribute | Ipamorelin | Hexarelin |
|---|---|---|
| Class | Growth Hormone Peptides | Growth Hormone |
| Description | A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin levels. | A synthetic hexapeptide growth hormone secretagogue with cardioprotective properties beyond GH release. |
| Dose in studies | 200-300 mcg 2-3x daily | 100-200 mcg 2-3x daily |
| Frequency | 2-3x daily | 2-3x daily, spread evenly |
| Half-life | ~2-3 hours | 60-70 minutes |
| Cycle length | 8-16 weeks on, 4-8 weeks off | 8-12 weeks on, 4 weeks off (desensitization) |
| Research level | 2/5 – Limited research | 2/5 – Limited research |
Ipamorelin: full profile · Hexarelin: full profile
Values from research literature – not medical advice.